Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease?

Author： Price Timothy J. Beeke Carol Ullah Shahid Padbury Robert Maddern Guy Roder David Townsend Amanda R. Moore James Roy Amitesh Tomita Yoko Karapetis Christos

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|6|830-835

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.6, 2015-03, pp. : 830-835

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemotherapy for Metastatic Colorectal Cancer

By Rosales Joseph Leong Lucille A.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 3, Iss. 4, 2005-07 ,pp. : 525-529

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

First-Line Treatment Strategies for Elderly Patients with Metastatic Colorectal Cancer

By Meulenbeld Hielke J. Creemers Geert-Jan

Drugs & Aging, Vol. 24, Iss. 3, 2007-01 ,pp. : 223-238

Adis International

Access to resources Recommend Favorite

Role of the Antiangiogenic Agent Bevacizumab in the Treatment of Elderly Patients with Metastatic Colorectal Cancer

By > Pietrantonio Filippo Martinetti Antonia Buzzoni Roberto Gevorgyan Arpine Bajetta Emilio

Drugs & Aging, Vol. 28, Iss. 2, 2011-02 ,pp. : 83-91

Adis International

Access to resources Recommend Favorite

Panitumumab: In the Treatment of Metastatic Colorectal Cancer

By Hoy Sheridan M. Wagstaff Antona J.

Drugs, Vol. 66, Iss. 15, 2006-01 ,pp. : 2005-2014

Adis International

Access to resources Recommend Favorite

FOLFOXIRI promising in metastatic colorectal cancer

Inpharma, Vol. 1, Iss. 1587, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite